BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1080 related articles for article (PubMed ID: 28774869)

  • 21. Age-Related Alterations of Nonalcoholic Steatohepatitis in Sprague-Dawley Rats Fed a High-Fat and High-Cholesterol Diet.
    Omagari K; Asakawa E; Sasao M; Narita S; Hisano M; Fukuda A; Suruga K; Ichimura M; Tsuneyama K
    J Nutr Sci Vitaminol (Tokyo); 2019; 65(4):349-356. PubMed ID: 31474685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease.
    Zhang H; Léveillé M; Courty E; Gunes A; N Nguyen B; Estall JL
    Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E863-E876. PubMed ID: 32924526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
    Liu C; Schönke M; Spoorenberg B; Lambooij JM; van der Zande HJP; Zhou E; Tushuizen ME; Andreasson AC; Park A; Oldham S; Uhrbom M; Ahlstedt I; Ikeda Y; Wallenius K; Peng XR; Guigas B; Boon MR; Wang Y; Rensen PCN
    Elife; 2023 Jan; 12():. PubMed ID: 36648330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
    Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
    Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
    [No Abstract]   [Full Text] [Related]  

  • 26. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model.
    Nozaki Y; Fujita K; Wada K; Yoneda M; Kessoku T; Shinohara Y; Imajo K; Ogawa Y; Nakamuta M; Saito S; Masaki N; Nagashima Y; Terauchi Y; Nakajima A
    BMC Gastroenterol; 2015 Apr; 15():42. PubMed ID: 25881230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular drivers of non-alcoholic steatohepatitis are sustained in mild-to-late fibrosis progression in a guinea pig model.
    Ipsen DH; Skat-Rørdam J; Tsamouri MM; Latta M; Lykkesfeldt J; Tveden-Nyborg P
    Mol Genet Genomics; 2019 Jun; 294(3):649-661. PubMed ID: 30759275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet.
    Kamada Y; Kiso S; Yoshida Y; Chatani N; Kizu T; Hamano M; Tsubakio M; Takemura T; Ezaki H; Hayashi N; Takehara T
    Am J Physiol Gastrointest Liver Physiol; 2011 Dec; 301(6):G1031-43. PubMed ID: 21885686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholic acid supplementation accelerates the progression of nonalcoholic fatty liver disease to the procarcinogenic state in mice fed a high-fat and high-cholesterol diet.
    Chun HJ; Shim YJ; Kwon YH
    J Nutr Biochem; 2022 Feb; 100():108869. PubMed ID: 34563665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.
    Depner CM; Torres-Gonzalez M; Tripathy S; Milne G; Jump DB
    J Nutr; 2012 Aug; 142(8):1495-503. PubMed ID: 22739374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet.
    Svop Jensen V; Fledelius C; Max Wulff E; Lykkesfeldt J; Hvid H
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33673227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatoprotective effects of the long-acting fibroblast growth factor 21 analog PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of nonalcoholic steatohepatitis.
    Nielsen MH; Gillum MP; Vrang N; Jelsing J; Hansen HH; Feigh M; Oró D
    Am J Physiol Gastrointest Liver Physiol; 2023 May; 324(5):G378-G388. PubMed ID: 36852934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.
    Kohli R; Kirby M; Xanthakos SA; Softic S; Feldstein AE; Saxena V; Tang PH; Miles L; Miles MV; Balistreri WF; Woods SC; Seeley RJ
    Hepatology; 2010 Sep; 52(3):934-44. PubMed ID: 20607689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model.
    Hayashida M; Hashimoto K; Ishikawa T; Miyamoto Y
    Int J Exp Pathol; 2019 Apr; 100(2):72-82. PubMed ID: 30887659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vertical Sleeve Gastrectomy Attenuates the Progression of Non-Alcoholic Steatohepatitis in Mice on a High-Fat High-Cholesterol Diet.
    Whang E; Liu Y; Kageyama S; Woo SL; Yang J; Lee R; Li Z; Ji H; Chen Y; Kupiec-Weglinski JW
    Obes Surg; 2019 Aug; 29(8):2420-2429. PubMed ID: 30982168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice.
    Tomita K; Teratani T; Suzuki T; Shimizu M; Sato H; Narimatsu K; Okada Y; Kurihara C; Irie R; Yokoyama H; Shimamura K; Usui S; Ebinuma H; Saito H; Watanabe C; Komoto S; Kawaguchi A; Nagao S; Sugiyama K; Hokari R; Kanai T; Miura S; Hibi T
    Hepatology; 2014 Jan; 59(1):154-69. PubMed ID: 23832448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic Mitochondrial SAB Deletion or Knockdown Alleviates Diet-Induced Metabolic Syndrome, Steatohepatitis, and Hepatic Fibrosis.
    Win S; Min RWM; Zhang J; Kanel G; Wanken B; Chen Y; Li M; Wang Y; Suzuki A; Aung FWM; Murray SF; Aghajan M; Than TA; Kaplowitz N
    Hepatology; 2021 Dec; 74(6):3127-3145. PubMed ID: 34331779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
    Lytle KA; Jump DB
    PLoS One; 2016; 11(1):e0146942. PubMed ID: 26761430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis.
    Mells JE; Fu PP; Kumar P; Smith T; Karpen SJ; Anania FA
    J Nutr Biochem; 2015 Mar; 26(3):285-92. PubMed ID: 25577467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.